Kamran Fariha, Andrade Anenisia C, Nella Aikaterini A, Clokie Samuel J, Rezvani Geoffrey, Nilsson Ola, Baron Jeffrey, Lui Julian C
Section on Growth and Development (F.K., A.A.N., G.R., J.B., J.C.L.) and Section on Neuroendocrinology (S.J.C.), Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, Maryland 20892; and Center for Molecular Medicine and Pediatric Endocrinology Unit (A.C.A., O.N.), Department of Women's and Children's Health, Karolinska Institutet and Karolinska University Hospital, SE-171 76 Stockholm, Sweden.
Mol Endocrinol. 2015 Jun;29(6):921-32. doi: 10.1210/me.2015-1047. Epub 2015 Apr 13.
Body growth is rapid in infancy but subsequently slows and eventually ceases due to a progressive decline in cell proliferation that occurs simultaneously in multiple organs. We previously showed that this decline in proliferation is driven in part by postnatal down-regulation of a large set of growth-promoting genes in multiple organs. We hypothesized that this growth-limiting genetic program is orchestrated by microRNAs (miRNAs). Bioinformatic analysis identified target sequences of the miR-29 family of miRNAs to be overrepresented in age-down-regulated genes. Concomitantly, expression microarray analysis in mouse kidney and lung showed that all members of the miR-29 family, miR-29a, -b, and -c, were strongly up-regulated from 1 to 6 weeks of age. Real-time PCR confirmed that miR-29a, -b, and -c were up-regulated with age in liver, kidney, lung, and heart, and their expression levels were higher in hepatocytes isolated from 5-week-old mice than in hepatocytes from embryonic mouse liver at embryonic day 16.5. We next focused on 3 predicted miR-29 target genes (Igf1, Imp1, and Mest), all of which are growth-promoting. A 3'-untranslated region containing the predicted target sequences from each gene was placed individually in a luciferase reporter construct. Transfection of miR-29 mimics suppressed luciferase gene activity for all 3 genes, and this suppression was diminished by mutating the target sequences, suggesting that these genes are indeed regulated by miR-29. Taken together, the findings suggest that up-regulation of miR-29 during juvenile life drives the down-regulation of multiple growth-promoting genes, thus contributing to physiological slowing and eventual cessation of body growth.
婴儿期身体生长迅速,但随后会减缓,最终停止,这是由于多个器官同时发生的细胞增殖逐渐减少所致。我们之前表明,这种增殖下降部分是由多个器官中大量促进生长基因的出生后下调所驱动的。我们假设这种限制生长的基因程序是由微小RNA(miRNA)精心编排的。生物信息学分析确定,miR-29家族miRNA的靶序列在随年龄下调的基因中过度富集。与此同时,对小鼠肾脏和肺的表达微阵列分析表明,miR-29家族的所有成员,即miR-29a、-b和-c,在1至6周龄时均强烈上调。实时PCR证实,miR-29a、-b和-c在肝脏、肾脏、肺和心脏中随年龄上调,并且从5周龄小鼠分离的肝细胞中的表达水平高于胚胎第16.5天的胚胎小鼠肝脏中的肝细胞。接下来,我们聚焦于3个预测的miR-29靶基因(Igf1、Imp1和Mest),它们均具有促进生长的作用。将包含每个基因预测靶序列的3'-非翻译区分别置于荧光素酶报告基因构建体中。转染miR-29模拟物可抑制所有3个基因的荧光素酶基因活性,并且通过突变靶序列可减弱这种抑制作用,这表明这些基因确实受miR-29调控。综上所述,这些发现表明,幼年时期miR-29的上调驱动了多个促进生长基因的下调,从而导致身体生长的生理减缓并最终停止。